Thymosin beta-4 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-03-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
| Property | Value | Notes |
|---|---|---|
| Dosage form | Lyophilized powder in sealed vial | Reconstituted before analytical or laboratory use |
| Reconstitution solvent | Sterile or bacteriostatic water | Bacteriostatic water limits microbial growth in multi-use vials |
| Typical working pH | Near neutral, buffered | Strongly acidic or basic conditions promote degradation |
| Stability indicator | Loss of main HPLC peak over time | Aggregation and oxidation are common degradation routes |
| Documentation | Batch certificate of analysis | Covers identity, purity and sometimes sterility testing |
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
A negative value of u indicates the presence of heteroatoms in the molecule and a half-integer value of u indicates the presence of an odd number of nitrogen atoms. On addition of heteroatoms, the molecular formula is adjusted by the equivalent mass of carbon and hydrogen. For example, adding N requires removing CH2 and adding O requires removing CH4.
Interpreting the course and origins of the conflict has been a source of heated controversy among historians, political scientists, and journalists. In particular, historians have sharply disagreed as to who was responsible for the breakdown of Soviet–US relations after the Second World War; and whether the conflict between the two superpowers was inevitable or could have been avoided. Historians have also disagreed on what exactly the Cold War was, what the sources of the conflict were, and how to disentangle patterns of action and reaction between the two sides. Although explanations of the origins of the conflict in academic discussions are complex and diverse, several general schools of thought on the subject can be identified. Historians commonly speak of three different approaches to the study of the Cold War: "orthodox" accounts, "revisionism", and "post-revisionism". "Orthodox" accounts place responsibility for the Cold War on the Soviet Union and its expansion further into Europe. "Revisionist" writers place more responsibility for the breakdown of post-war peace on the United States, citing a range of US efforts to isolate and confront the Soviet Union well before the end of World War II. "Post-revisionists" see the events of the Cold War as more nuanced and attempt to be more balanced in determining what occurred during the Cold War. Much of the historiography on the Cold War weaves together two or even all three of these broad categories.
== External links == NASA Spinoff homepage NASA Spinoff back issues archive NASA spinoff database Home and City – relating everyday life to NASA research NASA Benefits to You NASA Office of the Chief Technologist NASA STI Program "The Economic Impacts of the U.S. Space Program" by Jerome Schnee, Rutgers University "A Sustainable Method for Quantifying the Benefits of NASA Technology Transfer"
Commercial growers usually harvest the tulip bulbs in late summer and grade them into sizes; bulbs large enough to flower are sorted and sold, while smaller bulbs are sorted into sizes and replanted for sale in the future. Because tulip bulbs do not reliably come back every year, tulip varieties that fall out of favour with present aesthetic values have traditionally gone extinct. Unlike other flowers that do not suffer this same limitation, the tulip's historical forms do not survive alongside their modern incarnations. Tulip bulbs are typically planted around late summer and fall, in well-drained soils. Tulips should be planted 10 to 15 cm (4 to 6 inches) apart from each other. The recommended hole depth is 10 to 20 cm (4 to 8 inches) deep and is measured from the top of the bulb to the surface. Therefore, larger tulip bulbs would require deeper holes. Species of tulips are normally planted deeper.
Sources: en.wikipedia.org
For infants, non-pharmacological methods such as the use of a comfortable, padded chair and a sucrose or non-sucrose pacifier are more effective at reducing pain than a placebo, but the American Academy of Pediatrics (AAP) states that such methods are insufficient alone and should be used to supplement more effective techniques. A quicker procedure reduces duration of pain; use of the Mogen clamp was found to result in a shorter procedure time and less pain-induced stress than the use of the Gomco clamp or the Plastibell. The available evidence does not indicate that post-procedure pain management is needed. Some doctors recommend the use of petroleum jelly to prevent blood from adhering the genitals to the diaper during healing. For adults, topical anesthesia, ring block, dorsal penile nerve block (DPNB) and general anesthesia are all options, and the procedure requires four to six weeks of abstinence from masturbation or intercourse to allow the wound to heal.
The cars were cleaned with hot water or steam. Depending on the cargo, the cars might have undergone four hours of "pre-cooling" before loading, which entailed blowing in cold air through one ice hatch and allowing the warmer air to be expelled through the other hatches. The practice, dating back almost to the refrigerator car's inception, saved ice and resulted in fresher cargo. The cars' ice bunkers were filled, either manually from an icing dock, via mechanical loading equipment, or (in locations where demand for ice was sporadic) using specially designed field icing cars. The cars were delivered to the shipper for loading, and the ice was topped off. Depending on the cargo and destination, the cars may have been fumigated. The train would depart for the eastern markets. The cars were re-iced in transit approximately once a day. Upon reaching their destination, the cars were unloaded. If in demand, the cars would be returned empty to their point of origin. If not in demand, the cars would be cleaned and possibly used for a dry shipment.
Studies of food processing impact on public health and other outcomes, such as affordability, energy efficiency, food safety and sustainability benefit from the use of FPL. Several food ingredients, which have different FPL, are often used in food products. The highest FPL used to obtain ingredients for intermittent processing of formulated foods and the FPL of final processing, whichever is the highest, indicates the FPL of the final food. Final food products may be formulated using ingredients from several FPL which, when including ingredients or processing at FPL 3 and 4, are assigned to the highest FPL 4.
=== EC 2.1.3: Carboxy- and Carbamoyltransferases === EC 2.1.3.1: methylmalonyl-CoA carboxytransferase EC 2.1.3.2: aspartate carbamoyltransferase EC 2.1.3.3: ornithine carbamoyltransferase EC 2.1.3.4: deleted EC 2.1.3.5: oxamate carbamoyltransferase EC 2.1.3.6: putrescine carbamoyltransferase EC 2.1.3.7: 3-hydroxymethylcephem carbamoyltransferase EC 2.1.3.8: lysine carbamoyltransferase EC 2.1.3.9: N-acetylornithine carbamoyltransferase EC 2.1.3.10: malonyl-S-ACP:biotin-protein carboxyltransferase EC 2.1.3.11: N-succinylornithine carbamoyltransferase EC 2.1.3.13: The enzyme has been replaced by EC 6.1.2.2 EC 2.1.3.14: The enzyme has been replaced by EC 6.1.2.2 EC 2.1.3.15: acetyl-CoA carboxytransferase
=== Cap snatching in Hantaviridae === Cap snatching has also been investigated in depth for the family Hantaviridae (Bunyavirales). There is evidence that the N protein binds to the 5' cap and protects them from degradation by cellular machinery. The N protein accumulates in cytoplasmic cellular processing bodies (P bodies), sequestering the protected 5' caps as a pool of available primers for the RdRp to begin viral mRNA synthesis. There are four nucleotides on the vRNA that are adjacent the 5' cap for binding. The virus preferentially cleaves mRNA cap at a G residue 14 nucleotides downstream from the cap. Additionally, it usually cleaves caps from nonsense mRNA instead of actively translated mRNA. The N protein can guard host mRNA caps without P-bodies, but they are not used as efficiently by the RdRp. The Hantaviridae RdRp can also engage in a "prime and realign" mechanism: The host oligonucleotide primes mRNA transcription and initiates transcription with a terminal G residue. After several nucleotides are added, the nascent RNA realigns by moving two nucleotides backwards on the repeated terminal sequence (AUCAUCAUC) so that the host G is once again the first nucleotide, creating a 5' end extension.
Sources: en.wikipedia.org
=== Thrombotic disease === Various kits have a 93 to 95% sensitivity (true positive rate). For hospitalized patients, one study found the specificity to be about 50% (related to false positive rate) in the diagnosis of thrombotic disease.
The following is a list of events of the year 2026 in the United States, as well as predicted and scheduled events that have not yet occurred. July 4, 2026 was the 250th anniversary of the signing of the Declaration of Independence of the United States from Great Britain. Under the second year of Donald Trump's second presidency, the United States has engaged in attacks against its adversaries. In January 2026, the U.S. launched a military raid in Venezuela that captured its president Nicolás Maduro. In February 2026, the U.S. launched a major attack on Iran with Israel with the stated goal of regime change, killing its leader Ali Khamenei. Domestically, the US underwent two partial government shutdowns, with the first lasting four days, from January 31 to February 3, and the second lasting approximately 76 days, from February 14 to April 30, becoming the longest government shutdown in U.S. history and impacting the US Department of Homeland Security, with the core issue regarding the funding of Immigration and Customs Enforcement. In addition, 2026 saw the first major judicial actions against prediction markets, in particular Kalshi and the usage of its platform and other prediction markets to bypass state regulations on sports betting, with Nevada being the first to land a court-enforced ban of Kalshi and Arizona being the first to file criminal charges against Kalshi. In science and technology, the most prominent story so far has been the April 2026 NASA mission Artemis II, the first crewed deep-space mission since 1972.
pcALCL is the second most common lymphoma in the category of Cutaneous T cell lymphoma cutaneous T cell lymphomas that includes lymphomatoid papulosis, various borderline CD30-positive cutaneous T cell lymphomas, and mycosis fungoides. The median age at diagnosis for pcALC is 61 years. The disease has a male predominance and appears to be more common in Caucasian populations. Individuals with pcALCL typically present with reddish masses that initially appear in the skin or, much less frequently, the lymph nodes or various organs. These masses are nodules or tumors that are often ulcerated, greater than 2 cm in diameter, and localized to a single site. In 20% of cases, however, they occur in multiple sites. In about 10% cases followed for many years, pcALCL presenting as skin lesions progresses to extracutaneous sites, mainly to regional draining lymph nodes. Over these same long periods, however, the disease's lesions partially regress in about 50% of cases but then relapse in about 40% of cases.
The NAD⁺-II riboswitch (also called the pnuC RNA motif) is a riboswitch found in bacteria that regulates gene expression in response to levels of nicotinamide adenine dinucleotide (NAD⁺) and related metabolites, particularly nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). A shorter variant, the mini-NAD⁺-II riboswitch, was described in 2025 and is more phylogenetically widespread than the original class. NAD⁺ is a ubiquitous enzyme cofactor that functions as a carrier of hydride ions in metabolic oxidation-reduction reactions. It also serves as a source of activated adenosine monophosphate (AMP) for adenylation reactions and as a precursor of ADP-ribose. Because of NAD⁺'s essential role in cellular metabolism, bacteria must carefully regulate genes involved in both the de novo biosynthesis and salvage (recycling) of NAD⁺ and its many derivatives. Two classes of NAD riboswitches have been identified: NAD-I and NAD⁺-II.
Se-79, half-life of 327k years, is one of the long-lived fission products. Given the stability of its next lighter and heavier isotopes and the high cross section those isotopes exhibit for various neutron reactions, it is likely that the relatively low yield is due to Se-79 being destroyed in the reactor to an appreciable extent.
Sources: en.wikipedia.org
Desiccated storage at −20 °C is conventional, with −80 °C for extended periods. Vials should be warmed to room temperature before opening to prevent condensation on the powder.
It usually reports batch-specific results for purity by chromatography, identity by mass spectrometry, and sometimes peptide content and residual solvents. It applies only to the batch tested, not to a supplier's wider stock.
Purity describes the proportion of the chromatographic signal from the target compound, while peptide content measures how much of the vial's physical mass is peptide. Counter-ions, water and residual acid make up the remainder, so content values are commonly lower.
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.